Treatment response monitoring in chronic phase CML (CP-CML) patients receiving tyrosine kinase inhibitor (TKI) therapy in US Oncology network.
Kathryn S. Kolibaba
No relevant relationships to disclose
Hsing-wen Chung
No relevant relationships to disclose
Rahul Dhanda
No relevant relationships to disclose
Debra Rembert
No relevant relationships to disclose
Stephanie Lustgarten
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Jing L. Marantz
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Hui Huang
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD